We then uncovered that down-regulation of phospho-MARCKS was able to reduce intravasation of cancer cells, microvessel density and angiogenic factors, hallmarks of metastatic development of breast cancer [32], in our xenograft model. The gene discussed is MARCKS; the disease is breast carcinoma.